- ISIN
- US02080L1026
- CUSIP
- 02080L102
- Sector
- Healthcare
- IPO Date
- Jun 25, 2021
Highlights
- Market Cap
- $277.68M
- Enterprise Value
- $289.95M
- EPS (TTM)
- -$0.32
- Total Revenue (TTM)
- $41.80M
- Gross Profit (TTM)
- $14.22M
- EBITDA (TTM)
- -$11.55M
- Year Range
- $1.91 - $6.68
- ROA (TTM)
- -17.40%
- ROE (TTM)
- -26.44%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
TKNO Performance Chart
Alpha Teknova, Inc. (TKNO) is up 36.3% since the beginning of the year. At $5 per share, TKNO is trading 22.5% below its 52-week high of $7.
Loading charts...
Returns By Period
Alpha Teknova, Inc. (TKNO) has returned 36.32% so far this year and -9.60% over the past 12 months.
Alpha Teknova, Inc.
- 1D
- -3.54%
- 1M
- 52.35%
- YTD
- 36.32%
- 6M
- 17.19%
- 1Y
- -9.60%
- 3Y*
- 9.64%
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- 0.13%
- 1M
- 5.25%
- YTD
- 11.16%
- 6M
- 11.43%
- 1Y
- 28.20%
- 3Y*
- 21.12%
- 5Y*
- 12.66%
- 10Y*
- 13.75%
TKNO Monthly Returns History
Based on dividend-adjusted daily data since Jun 25, 2021, TKNO's average daily return is +0.04%, while the average monthly return is +2.30%. At this rate, an investment would double in approximately 2.5 years.
Historically, 39% of months were positive and 61% were negative. The best month was Jul 2024 with a return of +174.5%, while the worst month was Mar 2023 at -45.4%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 6 months.
On a daily basis, TKNO closed higher 47% of trading days. The best single day was Jul 17, 2024 with a return of +42.2%, while the worst single day was Mar 10, 2023 at -21.1%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -36.32% | 6.61% | 12.02% | 22.84% | 52.11% | -4.07% | 36.32% | ||||||
| 2025 | 5.87% | -26.47% | -20.15% | 28.52% | -13.49% | -14.90% | -7.94% | -4.42% | 43.29% | -15.19% | -10.86% | -18.80% | -54.49% |
| 2024 | -13.94% | -10.59% | -7.67% | -32.83% | -1.12% | -22.16% | 174.45% | 31.38% | -2.02% | 40.50% | 9.85% | 11.78% | 123.86% |
| 2023 | 5.67% | -9.06% | -45.39% | -36.15% | 103.17% | -30.47% | 26.97% | -42.48% | 43.08% | -28.67% | 2.51% | 82.84% | -33.87% |
| 2022 | -22.95% | 7.73% | -18.76% | -18.68% | -31.88% | 9.80% | -22.74% | -30.51% | -25.94% | 37.43% | 2.83% | 19.49% | -72.46% |
| 2021 | -5.08% | -6.36% | -14.45% | 30.93% | -7.63% | -2.74% | -8.41% | -18.08% |
Benchmark Metrics
Alpha Teknova, Inc. has an annualized alpha of -7.09%, beta of 1.35, and R2 of 0.06 versus S&P 500 Index. Calculated based on daily prices since June 28, 2021.
- This stock participated in 144.44% of S&P 500 Index downside but only -7.76% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.06 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -7.09%
- Beta
- 1.35
- R²
- 0.06
- Upside Capture
- -7.76%
- Downside Capture
- 144.44%
Return for Risk
Risk / Return Rank
TKNO ranks 36 for risk / return — below 36% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Alpha Teknova, Inc. (TKNO) and compare them to S&P 500 Index.
| TKNO | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.12 | 2.39 | -2.51 |
Sortino ratioReturn per unit of downside risk | 0.41 | 3.25 | -2.85 |
Omega ratioGain probability vs. loss probability | 1.04 | 1.43 | -0.39 |
Calmar ratioReturn relative to maximum drawdown | -0.14 | 3.11 | -3.25 |
Martin ratioReturn relative to average drawdown | -0.25 | 14.38 | -14.64 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Alpha Teknova, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Alpha Teknova, Inc. was 95.71%, occurring on Jul 5, 2024. The portfolio has not yet recovered.
The current Alpha Teknova, Inc. drawdown is 81.49%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2024 bear market2024 | -95.71%Jul 2024 | 3y 7d | — | 4y 11moJun 2021 - now |
Drawdown Indicators
| TKNO | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.71% | -56.78% | -38.93% |
Max Drawdown (1Y)Largest decline over 1 year | -68.76% | -9.10% | -59.66% |
Max Drawdown (3Y)Largest decline over 3 years | -79.61% | -18.90% | -60.71% |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -81.49% | 0.00% | -81.49% |
Average DrawdownAverage peak-to-trough decline | -74.98% | -10.72% | -64.26% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 37.83% | 1.97% | +35.86% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Alpha Teknova, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Alpha Teknova, Inc. is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for TKNO relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, TKNO has a P/S ratio of 6.6. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for TKNO in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, TKNO has a P/B value of 4.3. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with TKNO
Add Alpha Teknova, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with TKNO